Anaphylaxis produced by oxaliplatin
González-Mahave, I.; Lobera Iabairu, T.; Blasco Sarramián, A.; del Pozo Gil, M.D.; Zorrilla, M.; Vélez de Mendizábal, E.
Journal of Investigational Allergology and Clinical Immunology 15(1): 75-77
2005
ISSN/ISBN: 1018-9068 PMID: 15864887 Document Number: 592090
We are discussing two patients, with clinically compatible reactions, who display an immediate hypersensitive mechanism following the administration of oxaliplatin, confirmed by the performance of cutaneous tests.
Document emailed within 1 workday
Related Documents
Miyajima, R.; Kawazoe, H.; Tsuneoka, K.; Fujiwara, M.; Kojima, Y.; Yakushijin, Y. 2013: Preventive trial of preheating administration of oxaliplatin-diluted solution in combination with a hot compress for oxaliplatin-induced venous pain Gan to Kagaku Ryoho. Cancer and ChemoTherapy 40(4): 537-540Katayose, Y.; Nakagawa, K.; Onogawa, T.; Yoshida, H.; Motoi, F.; Naitoh, T.; Rikiyama, T.; Egawa, S.; Unno, M. 2011: A case of hypersensitivity reaction to reintroduced-oxaliplatin at the second course of oxaliplatin-based chemotherapy after neoadjuvant chemotherapy for liver metastases from colon cancer Gan to Kagaku Ryoho. Cancer and ChemoTherapy 38(13): 2651-2653
Mirvish, S.S.; Ramm, M.D.; Babcook, D.M.; Sams, J.P.; Panigot, M. 1987: Lipidic nitrosating agents produced from atmospheric nitrogen dioxide and a nitrosamine produced in vivo from amyl nitrite Iarc Scientific Publications 84: 315-318
Arzuhal, A.E.; Erden, G.; Ucar, F.; Yavuz Taslipinar, M.; Ozcan, N.; Guneyk, A.; Bulut, E.; Ginis, Z.; Ozdemir, S. 2016: Comparison of HbA1c analysers: Agilent 1100 HPLC using kits produced by Gordion Diagnostic (Turkey) with Premier Hb9210 using kits produced by Trinity Biotech (USA) in different patient groups Malaysian Journal of Pathology 38(2): 131-140
Singleton, E.; Smith, J.; Kavanagh, M.; Nolan, B.; White, B. 2007: Low risk of inhibitor formation in haemophilia patients after a change in treatment from Chinese hamster ovary cell-produced to baby hamster kidney cell-produced recombinant factor VIIi Thrombosis and Haemostasis 98(6): 1188-1192
Mani, S.; Manalo, J.; Bregman, D. 2000: Novel combinations with oxaliplatin Oncology 14(12 Suppl 11: 52-58
Zaniboni, A.; Meriggi, F. 2001: Oxaliplatin and fluorouracil: bolus coadministration regimens Tumori 87(6): A24-A25
Sato, J.; Terui, K.; Hayakari, M. 2009: Effect of preliminary medication on oxaliplatin hypersensitivity Gan to Kagaku Ryoho. Cancer and ChemoTherapy 36(7): 1125-1129
Reerink, O.; Mulder, N.H.; Szabo, B.G.; Hospers, G.A.P. 2004: 5FU and oxaliplatin-containing chemotherapy in two dihydropyrimidine dehydrogenase-deficient patients Anticancer Research 24(3b): 1969-1971
Ryan, D.P. 2000: Rectal cancer: integrating oxaliplatin into chemoradiation studies Oncology 14(12 Suppl 11: 38-41
Sagawa, T.; Sato, Y.; Abe, S.; Okuda, T.; Araki, N.; Takahari, D.; Okamoto, T.; Takayama, T.; Kato, J.; Niitsu, Y. 2006: Anaphylactic reaction to oxaliplatin--a case of colon cancer Gan to Kagaku Ryoho. Cancer and ChemoTherapy 33(13): 2093-2096
Zampino, M.G.; Lorizzo, K.; Rocca, A.; Locatelli, M.; Zorzino, L.; Manzoni, S.; Mazzetta, C.; Fazio, N.; Biffi, R.; De Braud, F. 2006: Oxaliplatin combined with 5-fluorouracil and methotrexate in advanced colorectal cancer Anticancer Research 26(3b): 2425-2428
Miyake, Y.; Ikeda, K.; Osawa, H.; Nagase, H.; Hoshi, M.; Doi, T.; Makari, Y.; Oshima, S.; Iijima, S.; Kurokawa, E.; Kikkawa, N. 2012: Fluoropyrimidines with oxaliplatin(L-OHP) as an adjuvant chemotherapy for Stage IIi colon cancer Gan to Kagaku Ryoho. Cancer and ChemoTherapy 39(12): 2161-2163
Rosique-Robles, D.; Vicent Verge, J.M.; Borrás-Blasco, J.; Giner-Marco, V.; Casterá, E.; Galan-Brotons, A.; Abad, J. 2007: Successful desensitization protocol for hypersensitivity reactions caused by oxaliplatin International Journal of Clinical Pharmacology and Therapeutics 45(11): 606-610
Matsuo, K.; Higuchi, M.; Sasaki, Y.; Iwatsubo, S.; Wada, Y.; Hasegawa, K.; Shirakawa, A.; Mishima, K.; Iwasaki, K.; Fujiwara, M.; Nishino, H. 2010: Analysis of a case of oxaliplatin - induced persistence sensory neuropathy Gan to Kagaku Ryoho. Cancer and ChemoTherapy 37(3): 551-554
Milczarek, M.; Rosinska, S.; Psurski, M.; Maciejewska, M.; Kutner, A.; Wietrzyk, J. 2013: Combined colonic cancer treatment with vitamin D analogs and irinotecan or oxaliplatin Anticancer Research 33(2): 433-444
Oikawa, Y.; Takahashi, M.; Takahashi, S.; Matsumoto, S.; Kenno, S.; Noguchi, K.; Kakisaka, T.; Tahara, M.; Yamagami, H.; Ishizu, H. 2016: Analysis of Oxaliplatin Combination Therapy for Unresectable or Recurrent Gastric Cancer Gan to Kagaku Ryoho. Cancer and ChemoTherapy 43(12): 1579-1581
Qian, J.; Qin, S.-k.; Mei, J.-f.; Chen, Y.-x.; Shao, Z.-j.; He, Z.-m. 2004: Oxaliplatin plus capecitabine as a second line chemotherapy for patients with advanced gastric cancer Zhonghua Zhong Liu Za Zhi 26(12): 746-748
Pietrantonio, F.; Di Bartolomeo, M.; Buzzoni, R.; Bajetta, E. 2010: Acute immune-mediated thrombocytopenia due to oxaliplatin administration: a case report Tumori 96(1): 154-156
Burz, C.; Berindan-Neagoe, I.; Balacescu, O.; Todor, N.; Pelau, D.; Floares, C.; Kacso, G.; Tanaselia, C.; Ursu, M.; Vlase, L.; Leucuta, S.E.; Cristea, V.; Irimie, A. 2010: Oxaliplatin in patients with metastatic colorectal cancer: efficacy and pharmacokinetics parameters Journal of BUON: Official Journal of the Balkan Union of Oncology 15(2): 263-269